Physician profile
Jay E Elder
NPI 1881689297
$2,056.67
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,519 · 2020: $439 · 2022: $99.00.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $530.89 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $309.32 | 2019-2020 | |
| Novo Nordisk INC | $275.15 | 2019-2020 | |
| Pfizer INC. | $185.07 | 2019 | |
| Novartis Pharmaceuticals Corporation | $150.10 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $147.45 | 2019-2020 | |
| Medtronic, INC. | $99.00 | 2022 | |
| Amgen INC. | $85.91 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $52.58 | 2019-2020 | |
| Lilly USA, LLC | $47.13 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.78 | 2019-2020 | |
| Glaxosmithkline, LLC. | $31.64 | 2019 | |
| Jazz Pharmaceuticals INC. | $28.96 | 2019-2020 | |
| Allergan, INC. | $20.32 | 2019 | |
| Daiichi Sankyo INC. | $12.09 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $12.00 | 2020 | |
| Sanofi Pasteur INC. | $11.50 | 2020 | |
| Avanir Pharmaceuticals, INC. | $11.07 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $8.71 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Elder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.